
Galectin Therapeutics (GALT) Earnings Dates & Reports
Galectin Therapeutics (GALT) Most Recent Earnings
Report DateAug 14, 2025
Period EndingQ2 2025
Est. EPS-$0.16
Actual EPS-$0.12
EarningsBeat
Galectin Therapeutics (GALT) Earnings
View the latest Galectin Therapeutics (GALT) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Galectin Therapeutics (GALT)
Order type
Buy in
Order amount
Est. shares
0 shares
Galectin Therapeutics (GALT) Earnings per Share (EPS) History
Signup for full accessBrowse free
Galectin Therapeutics (GALT) Latest Earnings
The value each GALT share was expected to gain vs. the value each share gained.
Galectin Therapeutics (GALT) reported its most recent earnings on Aug 14, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.12. This exceeded analysts' expectations of -$0.16 by 25.00%, marking a Beat.
For comparison, Galectin Therapeutics reported EPS of -$0.20 in the same quarter last year.
The company is expected to announce its next earnings report on 11/12/2025, with analysts projecting an EPS of -$0.11.
Galectin Therapeutics (GALT) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 13, 2025 | -$0.11 | Next earnings call Nov. 12, 2025 | ||
Q2 2025Aug 14, 2025 | -$0.16 | -$0.12 | -25.00% | |
Q1 2025May 15, 2025 | – | -$0.15 | — | |
Q4 2024Mar 31, 2025 | -$0.21 | -$0.19 | -9.52% | |
Q3 2024Nov 14, 2024 | -$0.20 | -$0.18 | -10.00% | |
Galectin Therapeutics (GALT) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Galectin Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 14, 2025 | — | — | — |
May 15, 2025 | — | — | — |
Mar 31, 2025 | — | — | — |
Nov 13, 2024 | — | — | — |
Galectin Therapeutics (GALT) Earnings FAQs
Galectin Therapeutics (GALT) last reported earnings on Aug 14, 2025 for Q2 2025, posting an EPS of -$0.12, which Beat the estimate of -$0.16 by 25.00%.
For Q2 2025, Galectin Therapeutics (GALT) reported an EPS of -$0.12, exceeding analysts' estimate of -$0.16 by 25.00%.
For Q2 2025, Galectin Therapeutics (GALT) Beat expectations with an actual EPS of -$0.12 vs. an estimated EPS of -$0.16.
Following the last earnings report on Aug 14, 2025, Galectin Therapeutics (GALT)'s stock price moved — from — to —.
The next Galectin Therapeutics (GALT) earnings call is scheduled for Nov. 12, 2025, where executives will discuss financial results and outlook.